Genotyping Market Report 2026 Market Outlook Supported By A Forecast 18% CAGR

The genotyping market is on the verge of remarkable expansion, driven by advancements in medicine and biotechnology. As precision medicine and agricultural research gain momentum, the demand for efficient genotyping technologies continues to surge. Let's explore the market's anticipated size, key players, emerging trends, and the various segments shaping its future.

Projected Market Growth and Size of the Genotyping Market
The genotyping market is expected to experience rapid development, reaching a valuation of $60.54 billion by 2030. This growth corresponds to a robust compound annual growth rate (CAGR) of 18.0%. Several factors contribute to this upward trend, including the wider adoption of precision medicine, the intensification of crop genetics research, decreasing costs associated with genotyping, increased investments from biopharmaceutical companies, and the merging of genotyping with clinical diagnostic techniques. Key trends poised to influence the market include greater use of genotyping in personalized healthcare, expansion into agricultural biotechnology, rising popularity of high-throughput genotyping platforms, growing demand for pharmacogenomics applications, and the integration of sophisticated bioinformatics tools within genotyping workflows.

The genotyping market size has grown rapidly in recent years. It will grow from $26.55 billion in 2025 to $31.26 billion in 2026 at a compound annual growth rate (CAGR) of 17.7%. The growth in the historic period can be attributed to advances in molecular biology, early genetic variation studies, growth of diagnostic laboratories, academic research adoption, development of microarray technologies.

Download a free sample of the genotyping market report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=12059&type=smp&utm_source=Open&utm_medium=Paid&utm_campaign=Aug_PR

Leading Organizations Driving the Genotyping Market Forward
Numerous prominent companies dominate the genotyping landscape, such as F. Hoffmann-La Roche Ltd., Thermo Fisher Scientific Inc., and Laboratory Corporation of America Holdings. Other significant players include Eurofins Scientific SE, Agilent Technologies, PerkinElmer Inc., Illumina Inc., Bio-Rad Laboratories Inc., and QIAGEN NV. The market also features specialized firms like BGI Genomics, LGC Biosearch Technologies, and 23andMe Inc. In addition, innovators such as Oxford Nanopore Technologies, Pacific Biosciences of California, and GenScript Biotech play important roles in advancing genotyping technologies globally.

Strategic Acquisitions Enhancing Market Position
A notable development occurred in February 2023 when NIMGenetics, a Spain-based provider of clinical genetic diagnostics, acquired Gene Predictis, a Switzerland-based precision medicine company. Although the transaction amount was undisclosed, this acquisition aims to strengthen NIMGenetics' foothold in Central Europe while expanding its genomics diagnostic capabilities. Gene Predictis specializes in polygenic risk scoring, pharmacogenomics testing, and preventive genetics services grounded in genotyping and genetic data interpretation, making this partnership a strategic move to enhance offerings in these advanced areas.

View the full genotyping market report:
https://www.thebusinessresearchcompany.com/report/genotyping-global-market-report?utm_source=Open&utm_medium=Paid&utm_campaign=Aug_PR

Innovative Trends Shaping the Genotyping Market Landscape
Companies in the genotyping industry are increasingly focusing on cutting-edge solutions like high-coverage whole genome sequencing (WGS), which provides detailed and comprehensive genetic analysis. For example, in September 2023, CD Genomics, a U.S.-based genomics and bioinformatics service provider, introduced its Genotyping by Sequencing (GBS) service. This approach leverages next-generation sequencing combined with restriction enzyme digestion to offer scalable, cost-effective genome-wide SNP genotyping tailored for large sample volumes. The GBS platform supports extensive marker coverage and multiplexing, enabling fast, precise genotyping across a wide variety of species, thereby accelerating genomic research.

Main Segments Covered in the Global Genotyping Market
This report segments the genotyping market into several key categories. By product and services, it includes instruments, reagents and kits, bioinformatics solutions, and genotyping services. Technological classifications cover microarrays, capillary electrophoresis, sequencing, polymerase chain reaction (PCR), matrix-assisted laser desorption or ionization (Maldi-Tof) mass spectrometry, and other emerging technologies. Applications range from pharmacogenomics and personalized medicine diagnostics to animal genetics, agricultural biotechnology, and other fields. End-users span pharmaceutical and biopharmaceutical companies, diagnostics and research laboratories, academic institutions, and various other sectors.

Detailed Subcategories Within the Market
Further breakdown includes instruments such as sequencers, PCR machines, microarrays, and genotyping platforms. Reagents and kits cover DNA extraction kits, PCR reagents, SNP genotyping kits, and next-generation sequencing (NGS) kits. Bioinformatics is divided into data analysis software, genomic data management tools, and cloud-based solutions. Genotyping services encompass contract research organizations (CRO) offerings, customized genotyping services, and sample preparation assistance. This comprehensive segmentation provides a clear view of how the genotyping market is structured and the diverse range of products and services it encompasses.

Our latest 2026 market reports provide expanded strategic and visual intelligence with market attractiveness scoring and analysis, total addressable market (TAM) analysis, company scoring matrix graphics and tables, Excel-based forecasting dashboards, market hotspots infographics, key technologies and future trend analysis, together with updated graphics and tables.

Reach out to us:
The Business Research Company: https://www.thebusinessresearchcompany.com/,
Americas +1 310-496-7795,
Europe +44 7882 955267,
Asia & Others +44 7882 955267 & +91 8897263534,
Email us at info@tbrc.info.

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Learn More About The Business Research Company
With over 30,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.Our flagship product, the Global Market Model (GMM), is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.